Immix Biopharma (IMMX) Surges in Rare-Disease Innovation With Breakthrough AL Amyloidosis Therapy
There are biotech companies that enter the rare-disease landscape with a single idea, and then there are those…
OpGen (OPGN) Could Be the Breakout Biotech of 2025: Here’s the Stunning Science Behind It
A growing urgency in modern medicine has placed enormous pressure on laboratories and hospitals to detect dangerous pathogens…
Johnson & Johnson (JNJ) Just Unlocked a Major Cancer Breakthrough — Here’s Why Investors Are Suddenly Bullish
There are companies in global healthcare whose influence spans generations, and one of the most recognizable among them…
The Rise of Scilex Holding (SCLX): How This Company Built a Billion-Dollar Opportunity in Pain Management
Scilex Holding Company (NASDAQ:SCLX) has emerged as one of the most distinctive players in the modern pharmaceutical landscape,…
Denali Therapeutics (DNLI) Crashes 8.3% Premarket After Pricing $200M Offering
Denali Therapeutics Inc (NASDAQ:DNLI) is a biotechnology company founded with the mission to confront some of the most…
NVO Stock Alert: Novo Nordisk (NVO) Just Bought Akero (AKRO) for $4.7B — And It May Have Secured the Next Blockbuster Drug
Novo Nordisk A/S (NYSE:NVO) is a global healthcare and biotechnology leader headquartered in Bagsværd, Denmark, with a legacy…
Nektar Therapeutics (NKTR) Skyrockets 295% YTD — Is This the Biggest Biotech Comeback of 2025?
Nektar Therapeutics (NASDAQ:NKTR) is a clinical-stage biopharmaceutical company that has built its foundation on advancing innovative immune therapies…
Aimei Health Technology (AFJK) Skyrockets 1,006% Before a 46% Crash — What’s Really Behind This SPAC Explosion?
Aimei Health Technology Co. Ltd. (NASDAQ:AFJK) is a blank check company incorporated in New York with the purpose…
Ocular Therapeutix (OCUL) Surges 382% in 3 Years
Ocular Therapeutix Inc (NASDAQ:OCUL) is a biotechnology company founded with the vision of transforming the way ophthalmic disorders…
Zevra Therapeutics (ZVRA) Poised for Growth After Adding High-Profile Biopharma CEO to Board
Zevra Therapeutics Inc. (NASDAQ:ZVRA) is a commercial-stage biopharmaceutical company that has evolved into a recognized leader in the…
Syndax Pharmaceuticals Inc (SNDX) Skyrockets 76.88% in 6 Months
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) is a clinical stage biopharmaceutical company that has evolved into one of the most…
Bright Minds Biosciences (DRUG) Appears 44% Undervalued — DCF Shows Fair Value at CA$182
Bright Minds Biosciences Inc. (NASDAQ:DRUG) is a clinical stage biopharmaceutical company that has steadily built its identity as…
Quantum BioPharma (QNTM) Takes Center Stage as CTV’s W5 Exposes Alleged $700M Stock Manipulation Scheme
Quantum BioPharma Ltd. (NASDAQ:QNTM), formerly known as FSD Pharma before its strategic transformation, has evolved into a rapidly…
Amarin (AMRN) Posts 17% Revenue Surge: Is This the Start of a Massive Turnaround?
Amarin Corporation plc (NASDAQ:AMRN) has evolved into one of the most closely watched companies in the global cardiovascular…
Cadrenal Therapeutics (CVKD) Surges in Attention After Q3 2025 Update Reveals Big Pipeline Moves
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) is an emerging biopharmaceutical company focused on developing next-generation anticoagulant therapies designed to…
Ardelyx (ARDX) Tops Q3 With $110.33M Revenue
Ardelyx Inc. (NASDAQ:ARDX) is a commercial-stage biopharmaceutical company focused on developing and delivering first-in-class medicines for patients suffering…
Kymera Therapeutics (KYMR) Jumps 10.2% in a Month—Is Wall Street Pricing in a Major 2026 Breakout?
Kymera Therapeutics Inc. (NASDAQ:KYMR), a publicly traded biotechnology company, was founded to pioneer the rapidly expanding field of…
Biodexa Pharmaceuticals (BDRX) Launches Phase 3 Trial for eRapa — Can This $2.81M Biotech Transform FAP Treatment?
Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for diseases with significant…